HomeCompareLHCG vs ARCC

LHCG vs ARCC: Dividend Comparison 2026

LHCG yields 1.18% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARCC wins by $3.1K in total portfolio value
10 years
LHCG
LHCG
● Live price
1.18%
Share price
$169.81
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$127.13
Full LHCG calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — LHCG vs ARCC

📍 ARCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLHCGARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LHCG + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LHCG pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LHCG
Annual income on $10K today (after 15% tax)
$100.11/yr
After 10yr DRIP, annual income (after tax)
$108.06/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, LHCG beats the other by $107.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LHCG + ARCC for your $10,000?

LHCG: 50%ARCC: 50%
100% ARCC50/50100% LHCG
Portfolio after 10yr
$22.9K
Annual income
$64.13/yr
Blended yield
0.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

LHCG
Analyst Ratings
10
Buy
11
Hold
Consensus: Hold
Price Target
$174.75
+2.9% upside vs current
Range: $154.00 — $190.00
Altman Z
4.0
Piotroski
7/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LHCG buys
3
ARCC buys
0
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$LHCG▼ Sell$1,001 - $15,0002022-06-21
Josh Gottheimer🏢 House$LHCG▼ Sell$1,001 - $15,0002022-05-09
Josh Gottheimer🏢 House$LHCG▲ Buy$1,001 - $15,0002021-11-04
Sara Jacobs🏢 House$LHCG▼ Sell$50,001 - $100,0002021-04-09
Sara Jacobs🏢 House$LHCG▲ Buy$15,001 - $50,0002021-02-19
Gilbert Cisneros🏢 House$LHCG▼ Sell$1,001 - $15,0002020-10-29
John A. Yarmuth🏢 House$LHCG▼ Sell$250,001 - $500,0002020-07-08
John A. Yarmuth🏢 House$LHCG▼ Sell$100,001 - $250,0002020-07-06
John A. Yarmuth🏢 House$LHCG▼ Sell$100,001 - $250,0002020-07-02
John A. Yarmuth🏢 House$LHCG▼ Sell$100,001 - $250,0002020-04-06
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLHCGARCC
Forward yield1.18%10.65%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$21.4K$24.5K
Annual income after 10y$127.13$1.14
Total dividends collected$1.2K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy
Analyst price target$174.75$21.88

Year-by-year: LHCG vs ARCC ($10,000, DRIP)

YearLHCG PortfolioLHCG Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$10,818$117.78$11,373$532.74$555.00ARCC
2$11,694$119.08$12,608$279.46$914.00ARCC
3$12,633$120.30$13,809$142.90$1.2KARCC
4$13,639$121.46$15,042$72.20$1.4KARCC
5$14,716$122.55$16,341$36.27$1.6KARCC
6$15,870$123.58$17,732$18.18$1.9KARCC
7$17,105$124.55$19,231$9.10$2.1KARCC
8$18,428$125.46$20,851$4.55$2.4KARCC
9$19,844$126.32$22,605$2.28$2.8KARCC
10$21,360$127.13$24,504$1.14$3.1KARCC

LHCG vs ARCC: Complete Analysis 2026

LHCGStock

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.

Full LHCG Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this LHCG vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LHCG vs SCHDLHCG vs JEPILHCG vs OLHCG vs KOLHCG vs MAINLHCG vs HTGCLHCG vs GBDCLHCG vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.